Literature DB >> 3004015

Epithelioid hemangioendothelioma. Report of a case with immuno-lectinhistochemical and ultrastructural demonstration of its vascular nature.

G Arnold, P J Klein, R Fischer.   

Abstract

The epithelioid hemangioendothelioma (EHE) is a rare vascular tumour of borderline malignancy, first described as a separate entity in 1982 by Weiss and Enzinger. The abundant cytoplasm of endothelial cells mimiking epithelioid appearances, prominent cytoplasmic vacuolization and barely perceptible lumina even in reticulin stains may result in EHE being mistaken for a signet ring cell carcinoma. In our case, difficulties in differential diagnosis were enhanced by the location of the tumour within an inguinal lymph node. The usefulness of FVIIIR: Ag- and UEA I- histochemistry in ascertaining the endothelial nature of this tumour is demonstrated, in correlation with electron microscopic data. The different reaction sites of these markers are striking and typical: FVIIIR: Ag displays a granular or diffuse cytoplasmic reaction, whereas UEA I provides a linear staining of vacuoles and luminal surfaces.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3004015     DOI: 10.1007/bf00707700

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  8 in total

1.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

2.  Ulex europaeus I lectin as a marker for tumors derived from endothelial cells.

Authors:  M Miettinen; H Holthofer; V P Lehto; A Miettinen; I Virtanen
Journal:  Am J Clin Pathol       Date:  1983-01       Impact factor: 2.493

3.  Lectins as fluorescence microscopic markers for saccharides in the human kidney.

Authors:  H Holthöfer; I Virtanen; E Pettersson; T Törnroth; O Alfthan; E Linder; A Miettinen
Journal:  Lab Invest       Date:  1981-11       Impact factor: 5.662

4.  Immunohistochemical identification of factor VIII-related antigen in endothelial cells of cutaneous lesions of alleged vascular nature.

Authors:  W H Burgdorf; K Mukai; J Rosai
Journal:  Am J Clin Pathol       Date:  1981-02       Impact factor: 2.493

5.  Epithelioid hemangioendothelioma: a vascular tumor often mistaken for a carcinoma.

Authors:  S W Weiss; F M Enzinger
Journal:  Cancer       Date:  1982-09-01       Impact factor: 6.860

6.  The significance of lectin receptors for the evaluation of hormone dependence in breast cancer.

Authors:  P J Klein; M Vierbuchen; J Fischer; K D Schulz; G Farrar; G Uhlenbruck
Journal:  J Steroid Biochem       Date:  1983-07       Impact factor: 4.292

7.  Factor VII related antigen as an endothelial cell marker in benign and malignant diseases.

Authors:  M Sehested; K Hou-Jensen
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1981

8.  NEW CYTOPLASMIC COMPONENTS IN ARTERIAL ENDOTHELIA.

Authors:  E R WEIBEL; G E PALADE
Journal:  J Cell Biol       Date:  1964-10       Impact factor: 10.539

  8 in total
  4 in total

1.  Fatal epithelioid haemangioendothelioma presenting in the lung and liver.

Authors:  T O Ekfors; K Joensuu; I Toivio; P Laurinen; L Pelttari
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

2.  Haemangioendothelioma of paranasal sinuses with intracranial extension.

Authors:  S C Gupta; S L Tewarson; M Malhotra
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2006-04

Review 3.  Primary epithelioid haemangioendothelioma of the liver: case report and review of the literature.

Authors:  R K Pokharna; P K Garg; S D Gupta; U Dutta; R K Tandon
Journal:  J Clin Pathol       Date:  1997-12       Impact factor: 3.411

Review 4.  Degenerative cervical myelopathy - update and future directions.

Authors:  Jetan H Badhiwala; Christopher S Ahuja; Muhammad A Akbar; Christopher D Witiw; Farshad Nassiri; Julio C Furlan; Armin Curt; Jefferson R Wilson; Michael G Fehlings
Journal:  Nat Rev Neurol       Date:  2020-01-23       Impact factor: 42.937

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.